These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

459 related items for PubMed ID: 16088440

  • 1. The role of corticosteroids in chronic obstructive pulmonary disease.
    Calverley PM.
    Semin Respir Crit Care Med; 2005 Apr; 26(2):235-45. PubMed ID: 16088440
    [Abstract] [Full Text] [Related]

  • 2. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
    Baker WL, Baker EL, Coleman CI.
    Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
    [Abstract] [Full Text] [Related]

  • 3. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
    Sobieraj DM, White CM, Coleman CI.
    Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
    [Abstract] [Full Text] [Related]

  • 4. Effects of corticosteroids on lung function in asthma and chronic obstructive pulmonary disease.
    Donohue JF, Ohar JA.
    Proc Am Thorac Soc; 2004 Aug; 1(3):152-60. PubMed ID: 16113428
    [Abstract] [Full Text] [Related]

  • 5. Effect of corticosteroids on exacerbations of asthma and chronic obstructive pulmonary disease.
    Calverley PM.
    Proc Am Thorac Soc; 2004 Aug; 1(3):161-6. PubMed ID: 16113429
    [Abstract] [Full Text] [Related]

  • 6. Role of bronchodilators in chronic obstructive pulmonary disease.
    Weder MM, Donohue JF.
    Semin Respir Crit Care Med; 2005 Apr; 26(2):221-34. PubMed ID: 16088439
    [Abstract] [Full Text] [Related]

  • 7. Inhaled corticosteroids in chronic obstructive pulmonary disease: a review.
    Telenga ED, Kerstjens HA, Postma DS, Ten Hacken NH, van den Berge M.
    Expert Opin Pharmacother; 2010 Feb; 11(3):405-21. PubMed ID: 20102305
    [Abstract] [Full Text] [Related]

  • 8. Optimizing treatment of chronic obstructive pulmonary disease: an assessment of current therapies.
    Wise RA, Tashkin DP.
    Am J Med; 2007 Aug; 120(8 Suppl 1):S4-13. PubMed ID: 17678942
    [Abstract] [Full Text] [Related]

  • 9. [Friend or foe: combination therapy with inhaled corticosteroids and long-acting beta2-agonists in chronic obstructive pulmonary disease (COPD)].
    Gillissen A, Gessner C, Hoheisel G, Juergens U.
    Pneumologie; 2008 Jul; 62(7):430-7. PubMed ID: 18398787
    [Abstract] [Full Text] [Related]

  • 10. Exacerbations of chronic obstructive pulmonary disease.
    Wedzicha JA, Donaldson GC.
    Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
    [Abstract] [Full Text] [Related]

  • 11. Inhaled corticosteroids and the risk of fracture in chronic obstructive pulmonary disease.
    Pujades-Rodríguez M, Smith CJ, Hubbard RB.
    QJM; 2007 Aug; 100(8):509-17. PubMed ID: 17609226
    [Abstract] [Full Text] [Related]

  • 12. Inhaled corticosteroids as combination therapy with beta-adrenergic agonists in airways disease: present and future.
    Chung KF, Caramori G, Adcock IM.
    Eur J Clin Pharmacol; 2009 Sep; 65(9):853-71. PubMed ID: 19557399
    [Abstract] [Full Text] [Related]

  • 13. Steroid therapy in chronic obstructive pulmonary disease.
    OBrien A, Ward NS.
    Med Health R I; 2002 Feb; 85(2):52-5. PubMed ID: 11881166
    [Abstract] [Full Text] [Related]

  • 14. The place of inhaled corticosteroids in chronic obstructive pulmonary disease.
    Selroos O.
    Curr Med Res Opin; 2004 Oct; 20(10):1579-93. PubMed ID: 15462691
    [Abstract] [Full Text] [Related]

  • 15. Clinical effects of inhaled corticosteroids in chronic obstructive pulmonary disease.
    Jones PW.
    Proc Am Thorac Soc; 2004 Oct; 1(3):167-70. PubMed ID: 16113430
    [Abstract] [Full Text] [Related]

  • 16. A double-blind crossover study comparing the safety and efficacy of three weeks of Flu/Sal 250/50 bid plus albuterol 180 ug prn q4 hours to Flu/Sal 250/50 bid plus albuterol/Ipratropium bromide 2 puffs prn q4 hours in patients with chronic obstructive pulmonary disease.
    Balkissoon R, Make B.
    COPD; 2008 Aug; 5(4):221-7. PubMed ID: 18671147
    [Abstract] [Full Text] [Related]

  • 17. Survival with tiotropium compared to long-acting Beta-2-agonists in Chronic Obstructive Pulmonary Disease.
    Gershon AS, Wang L, To T, Luo J, Upshur RE.
    COPD; 2008 Aug; 5(4):229-34. PubMed ID: 18671148
    [Abstract] [Full Text] [Related]

  • 18. Association between CRHR1 polymorphism and improved lung function in response to inhaled corticosteroid in patients with COPD.
    Kim WJ, Sheen SS, Kim TH, Huh JW, Lee JH, Kim EK, Lee JH, Lee SM, Lee S, Lim SY, Shin TR, Yoon HI, Oh YM, Lee SD.
    Respirology; 2009 Mar; 14(2):260-3. PubMed ID: 19210659
    [Abstract] [Full Text] [Related]

  • 19. The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding.
    Tashkin DP.
    Am J Med; 2006 Oct; 119(10 Suppl 1):63-72. PubMed ID: 16996901
    [Abstract] [Full Text] [Related]

  • 20. [Inhaled corticosteroids for COPD].
    Dekhuijzen PN.
    Ned Tijdschr Geneeskd; 2003 Jul 19; 147(29):1398-404. PubMed ID: 12894463
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.